APA (7th ed.) Citation

Disanto, G., Ripellino, P., Riccitelli, G. C., Sacco, R., Scotti, B., Fucili, A., . . . Zecca, C. (2021). De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis. Multiple sclerosis, 27(8), 1230. https://doi.org/10.1177/1352458520952036

Chicago Style (17th ed.) Citation

Disanto, Giulio, et al. "De-escalating Rituximab Dose Results in Stability of Clinical, Radiological, and Serum Neurofilament Levels in Multiple Sclerosis." Multiple Sclerosis 27, no. 8 (2021): 1230. https://doi.org/10.1177/1352458520952036.

MLA (9th ed.) Citation

Disanto, Giulio, et al. "De-escalating Rituximab Dose Results in Stability of Clinical, Radiological, and Serum Neurofilament Levels in Multiple Sclerosis." Multiple Sclerosis, vol. 27, no. 8, 2021, p. 1230, https://doi.org/10.1177/1352458520952036.